299 articles
Susana Banerjee, Consultant Medical Oncologist and Research Lead for the Gynecology unit at Royal Marsden NHS and lead investigator discusses results fr...
Dirk Huebner, MD, Chief Medical Officer at Aptevo Therapeutics, a biotech company, discusses the company's focus on bringing novel immuno-oncology thera...
Douglas Rex, MD, Distinguished Professor Emeritus at Indiana University School of Medicine and a full-time clinical gastroenterologist at Indiana Univer...
Meredith Manning, President of the Americas at PharmaEssentia, a global biotech, discusses the company’s work utilizing the power of interferons, a na...
Tahamtan (Tahi) Ahmadi, M.D., Ph.D., Executive Vice President & Chief Medical Officer, Head of Experimental Medicines at Genmab, an international biotec...
Sledge, Jr., newly appointed Executive Vice President and Chief Medical Officer of Caris Life Sciences, discusses why he made the move to Caris and the ...
Rick Baehner, MD, Chief Medical Officer of Precision Oncology at Exact Sciences discusses new data presented at the 2022 San Antonio Breast Cancer Sympo...
Robert Risinger, Chief Medical Officer, Neuroscience at BioXcel Therapeutics, a biopharmaceutical company that uses artificial intelligence (AI) to iden...
Mike Krams, Chief Quantitative Medicine Officer at Exscientia plc discusses the first clinical trial application (CTA) approval in ...
Metastatic breast cancer or mBC, also known as stage 4, cannot be cured and therefore brings a different experience than earlier stage cancer.